Urine exosomes for non-invasive assessment of gene expression and mutations of prostate cancer

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Motamedinia, Piruz ^a   Scott, Anna N ^b   Bate, Kendall L ^b   Sadeghi, Neda ^a   Salazar, Guillermo ^b   Shapiro, Edan ^a   Ahn, Jennifer ^a   Lipsky, Michael ^a   Lin, James ^a   Hruby, Greg W ^a   Badani, Ketan K ^a,c   Petrylak, Daniel P ^a,d   Benson, Mitchell C ^a   Donovan, Michael J ^b,c   Comper, Wayne D ^b   McKiernan, James M ^a   Russo, Leileata M ^b,e  

^a NewYork Presbyterian Hospital   (United States)

^b Exosome Diagnostics Inc   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; RNA; TMPRSS2-ERG FUSION PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; CASE CONTROL STUDY; EXOSOME; GENE EXPRESSION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MUTATION; PILOT STUDY; PROSTATE; PROSTATIC NEOPLASMS; URINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; EXOSOMES; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MUTATION; ONCOGENE PROTEINS, FUSION; PILOT PROJECTS; PROSTATE; PROSTATIC NEOPLASMS; RNA, NEOPLASM;

EID: 84976380582     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154507     Document Type: Article

References (31)

1. Pisitkun T, Shen RF, Knepper MA (2004) Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 101: 13368–13373. PMID: 15326289
2. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654–659. PMID: 17486113
3. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10: 1470–1476. doi: 10.1038/ncb1800 PMID: 19011622
4. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277–300. doi: 10.3322/caac.20073 PMID: 20610543
5. Chou R, Croswell JM, Dana T, Bougatsos C, Blazina I, Fu R, et al. (2011) Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 155: 762–771. doi: 10.7326/0003-4819-155-11-201112060-00375 PMID: 21984740
6. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. (2012) Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 366: 981–990. doi: 10.1056/NEJMoa1113135 PMID: 22417251
7. Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, et al. (2010) Mortality results from the Goteborg randomised population-based prostate-cancer screening trial. Lancet Oncol 11: 725–732.
8. Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, et al. (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360: 1310–1319. doi: 10.1056/ NEJMoa0810696 PMID: 19297565
9. Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakefield XO, et al. (2009) Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer 100: 1603–1607. doi: 10.1038/sj.bjc.6605058 PMID: 19401683
10. Miranda KC, Bond DT, McKee M, Skog J, Paunescu TG, Da Silva N, et al. (2010) Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int 78: 191–199. doi: 10.1038/ki.2010.106 PMID: 20428099
11. Miranda KC, Bond DT, Levin JZ, Adiconis X, Sivachenko A, Russ C, et al. (2014) Massively parallel sequencing of human urinary exosome/microvesicle RNA reveals a predominance of non-coding RNA. PLoS One 9: e96094. doi: 10.1371/journal.pone.0096094 PMID: 24816817
12. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644–648. PMID: 16254181
13. Perner S, Mosquera JM, Demichelis F, Hofer MD, Paris PL, Simko J, et al. (2007) TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol 31: 882–888. PMID: 17527075
14. Soller MJ, Isaksson M, Elfving P, Soller W, Lundgren R, Panagopoulos I (2006) Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer. Genes Chromosomes Cancer 45: 717–719. PMID: 16575875
15. Winnes M, Lissbrant E, Damber JE, Stenman G (2007) Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer. Oncol Rep 17: 1033–1036. PMID: 17390040
16. Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, et al. (1999) DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 59: 5975–5979. PMID: 10606244
17. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917–921. PMID: 9256286
18. Petrovics G, Liu A, Shaheduzzaman S, Furusato B, Sun C, Chen Y, et al. (2005) Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. Oncogene 24: 3847–3852. PMID: 15750627
19. Wang MC, Papsidero LD, Kuriyama M, Valenzuela LA, Murphy GP, Chu TM (1981) Prostate antigen: a new potential marker for prostatic cancer. Prostate 2: 89–96. PMID: 6169079
20. Deras IL, Aubin SM, Blase A, Day JR, Koo S, Partin AW, et al. (2008) PCA3: a molecular urine assay for predicting prostate biopsy outcome. J Urol 179: 1587–1592. doi: 10.1016/j.juro.2007.11.038 PMID: 18295257
21. Laxman B, Tomlins SA, Mehra R, Morris DS, Wang L, Helgeson BE, et al. (2006) Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. Neoplasia 8: 885–888. PMID: 17059688
22. Laxman B, Morris DS, Yu J, Siddiqui J, Cao J, Mehra R, et al. (2008) A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res 68: 645–649. doi: 10. 1158/0008-5472.CAN-07-3224 PMID: 18245462
23. Rice KR, Chen Y, Ali A, Whitman EJ, Blase A, Ibrahim M, et al. (2010) Evaluation of the ETS-related gene mRNA in urine for the detection of prostate cancer. Clin Cancer Res 16: 1572–1576. doi: 10. 1158/1078-0432.CCR-09-2191 PMID: 20160063
24. Tomlins SA, Aubin SM, Siddiqui J, Lonigro RJ, Sefton-Miller L, Miick S, et al. (2011) Urine TMPRSS2: ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. Sci Transl Med 3: 94ra72. doi: 10.1126/scitranslmed.3001970 PMID: 21813756
25. Hessels D, Smit FP, Verhaegh GW, Witjes JA, Cornel EB, Schalken JA (2007) Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer. Clin Cancer Res 13: 5103–5108. PMID: 17785564
26. Salami SS, Schmidt F, Laxman B, Regan MM, Rickman DS, Scherr D, et al. (2013) Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer. Urol Oncol 31: 566–571. doi: 10.1016/j.urolonc.2011.04.001 PMID: 21600800
27. Leitzmann MF, Rohrmann S (2012) Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates. Clin Epidemiol 4: 1–11.
28. Bories PN, Younes P, Zerbib M, Denjean L, Popovici T, Cynober L, et al. (2013) TMPRSS2-ERG fusion transcripts in matched urine and needle rinse material after biopsy for the detection of prostate cancer. Clin Chem 59: 245–251. doi: 10.1373/clinchem.2012.192260 PMID: 23045253
29. Rostad K, Hellwinkel OJ, Haukaas SA, Halvorsen OJ, Oyan AM, Haese A, et al. (2009) TMPRSS2: ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis. APMIS 117: 575–582. doi: 10.1111/j.1600-0463.2009.02517.x PMID: 19664128
30. Leyten GH, Hessels D, Jannink SA, Smit FP, de Jong H, Cornel EB, et al. (2014) Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer. Eur Urol 65: 534–542. doi: 10.1016/j.eururo.2012.11.014 PMID: 23201468
31. Svensson MA, Perner S, Ohlson AL, Day JR, Groskopf J, Kirsten R, et al. (2014) A comparative study of ERG status assessment on DNA, mRNA, and protein levels using unique samples from a Swedish biopsy cohort. Appl Immunohistochem Mol Morphol 22: 136–141. doi: 10.1097/PDM. 0b013e31829e0484 PMID: 24517914